A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Phendimetrazine
Prasugrel
Potassium may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Alogliptin
Potassium may increase the excretion rate of Alogliptin which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Icatibant
Potassium may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Ipilimumab
Potassium may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Pentaerythritol tetranitrate
Potassium may increase the excretion rate of Pentaerythritol tetranitrate which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Brivaracetam
Potassium may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Migalastat
Potassium may increase the excretion rate of Migalastat which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Ezogabine
Potassium may increase the excretion rate of Ezogabine which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Milnacipran
Potassium may increase the excretion rate of Milnacipran which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Pegaptanib
Potassium may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Lorcaserin
Potassium may increase the excretion rate of Lorcaserin which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Roflumilast
Potassium may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Dexketoprofen
Dexketoprofen may increase the excretion rate of Potassium which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Alclofenac
Potassium may increase the excretion rate of Alclofenac which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Propacetamol
Potassium may increase the excretion rate of Propacetamol which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Nicorandil
Potassium may increase the excretion rate of Nicorandil which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Arotinolol
Potassium may increase the excretion rate of Arotinolol which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Trimebutine
Potassium may increase the excretion rate of Trimebutine which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Benzydamine
Potassium may increase the excretion rate of Benzydamine which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Ammonium chloride
Potassium may increase the excretion rate of Ammonium chloride which could result in a lower serum level and potentially a reduction in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3